Advanced practice providers (APPs) in oncology were divided in their willingness to consult on or prescribe medications for medical aid in dying (MAID) if it was legal for APPs to…
The Oncology Connection Sexual health is affected by every type of cancer, not just cancers involving the reproductive organs, and it is affected by every treatment modality—surgery, radiation, hormone therapy,…
Haleigh Mistry, MS, PA-C “For me, being a mother made me a better professional, because coming home every night to my girls reminded me what I was working for. And…
Beth Sandy, MSN, CRNP For my entire career as an oncology nurse practitioner, the gold standard for meaningful endpoints in oncology therapeutic trials has been to show a benefit in…
Bo Gamble Payers of all types have increased their focus on quality and value over the past 10 years. This is particularly true with Medicare, including the Merit-Based Incentive Payment…
Ryan Beechinor, PharmD, BCPS, BCOP Palbociclib (Ibrance, Pfizer) is FDA-approved for the treatment of human epidermal growth factor receptor 2-negative (HER2-) breast cancer both as initial endocrine-based therapy as well…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP Multiple myeloma (MM) is the second most common hematological malignancy; it is characterized by the clonal proliferation of plasma cells, and it is incurable. Despite…
The Oncology Connection In 2017, Stanford Health Care’s advanced practice provider (APP) turnover rate was 18.1%, which was 50% higher than the national average of 12%. Following the implementation of…